O
Oppenheimer Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
726
ADMA Biologics
ADMA
$3.92B
| $16.42 | $7 |
57%
downside
| Outperform |
7 May ‘20
5 years ago |
|
|
727
Wyndham Hotels & Resorts
WH
$6.71B
| $87.90 | $55 |
37%
downside
| Outperform |
4 May ‘20
5 years ago |
|
|
728
Visa
V
$664B
|
GG
Glenn Greene
| $342.30 | $190 |
44%
downside
| Outperform |
1 May ‘20
5 years ago |
|
729
Jazz Pharmaceuticals
JAZZ
$7.88B
| $129.85 | $141 |
9%
upside
| Outperform |
30 Apr ‘20
5 years ago |
|
|
730
CarGurus
CARG
$3.59B
| $35.94 | $24 |
33%
downside
| Outperform |
20 Apr ‘20
5 years ago |
|
|
731
Twin Disc
TWIN
$184M
|
NK
Noah Kaye
| $13.39 | $10 |
25%
downside
| Outperform |
17 Apr ‘20
5 years ago |
|
732
WhiteHorse Finance
WHF
$202M
|
CK
Chris Kotowski
| $8.69 | $13 |
50%
upside
| Outperform |
13 Apr ‘20
5 years ago |
|
733
SLR Investment Corp
SLRC
$917M
|
AT
Allison Taylor
| $16.80 | $19 |
13%
upside
| Outperform |
13 Apr ‘20
5 years ago |
|
734
New Mountain Finance
NMFC
$1.12B
|
CK
Chris Kotowski
| $10.56 | $11 |
4%
upside
| Outperform |
13 Apr ‘20
5 years ago |
|
735
Ares Capital
ARCC
$15.9B
|
CK
Chris Kotowski
| $22.49 | $16 |
29%
downside
| Outperform |
13 Apr ‘20
5 years ago |
|
736
Bionano Genomics
BNGO
$19.9M
|
KD
Kevin DeGeeter
| $4.26 | $900 |
21,027%
upside
| Outperform |
8 Apr ‘20
5 years ago |
|
737
Varonis Systems
VRNS
$6.45B
|
SE
Shaul Eyal
| $57.57 | $23.33 |
59%
downside
| Outperform |
7 Apr ‘20
5 years ago |
|
738
Tempest Therapeutics
TPST
$48.2M
|
JO
Jay Olson
| $10.85 | $30 |
177%
upside
| Perform |
7 Apr ‘20
5 years ago |
|
739
Travel + Leisure Co
TNL
$4.1B
|
IZ
Ian Zaffino
| $63 | $40 |
37%
downside
| Outperform |
30 Mar ‘20
5 years ago |
|
740
Sony
SONY
$171B
|
AU
Andrew Uerkwitz
| $28.67 | $70 |
144%
upside
| Outperform |
18 Mar ‘20
5 years ago |
|
741
Apple
AAPL
$3.53T
|
AU
Andrew Uerkwitz
| $237.88 | $20 |
92%
downside
| Outperform |
2 Mar ‘20
5 years ago |
|
742
Madison Square Garden
MSGS
$4.88B
| $202.99 | $365 |
80%
upside
| Outperform |
24 Jan ‘20
5 years ago |
|
|
743
Apellis Pharmaceuticals
APLS
$3.4B
| $26.91 | $62 |
130%
upside
| Outperform |
8 Jan ‘20
5 years ago |
|